The NITD is entirely dependent on the early formation of partnerships on a global scale. This is already important for early research activities such as target identification and high throughput screening. For later stages of the drug development process, as well as the outreach to patients, partnerships and alliances are essential for making treatments available to developing countries and at low cost.
Within the Novartis Group, the NITD is collaborating with the Novartis Institutes for Biomedical Research, The Genomics Institute of the Novartis Foundation, and is interacting with the Infectious Disease Business Franchise of Novartis Pharma AG.
Externally, the Institute has built strong relationships with leading members of the local, regional, and global scientific and clinical community as well as international organizations such as the World Health Organisation, Ministries of health of the region and non-governmental organizations including:
